Fig. 1From: Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson’s diseaseSchematic representation of the experimental design. Each mouse received an injection of either saline or MPTP solution for 5 consecutive days. One week after the final injection, the mice were administered l -dopa (5, 10, and 20 mg/kg) along with KD5040 daily for 8 days. M: MPTP, K: KD5040, L: l -dopaBack to article page